A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression {ASCEND}

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 184 participants.

Also called NCT02358343

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 184 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02358343
Other papers using this trial's data
  • Comparative Efficacy of Therapies for Treatment of Depression for Patients Undergoing Maintenance Hemodialysis: A Randomized Clinical Trial Annals of internal medicine, 2019-03-19 DOI, PubMed 30802897

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02358343. Randomized; no masking; primary purpose treatment. Start 2015-03-23 (actual); primary completion 2017-11-15 (actual). Results posted on 2019-07-23.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression {ASCEND}
Acronym
ASCEND
Condition
Depression
Condition
End Stage Renal Disease
Intervention (Behavioral)
Engagement Interview
Intervention (Behavioral)
Cognitive Behavioral Therapy
Intervention (Drug)
Antidepressant Drug Therapy
Lead sponsor
University of Washington (class: other)
Collaborator
University of Texas (class: other)
Collaborator
University of New Mexico (class: other)
Collaborator
Patient-Centered Outcomes Research Institute (class: other)

Record details

Record id
cardio:ct-nct02358343
Content hash
dc343075333d6f06e823a1557c56545f14a3eb15ce017024ba79d2f65712f28d